Study shows value of HRQOL assessment in small cell lung cancer
Tuesday, January 28, 2014 - 13:30
in Health & Medicine
A new study found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy. It provides valuable information for those treatments where better health-related quality of life is associated with overall survival benefit. The study also found that even though the overall standard for reporting health-related quality of life was acceptable, there is still need for improvement regarding reporting in randomized clinical trials to optimize value.